4001 - 4050 of 6257 Results
Title
Year
- Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care Approaches2022OPENTitle: Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care ApproachesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 7Start Page: 1057End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12071057Best OA location URL: https://www.mdpi.com/2075-4426/12/7/1057/pdf?version=1656473097Citation Count: 3
- Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain2022OPENTitle: Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat BrainJournal Name: MoleculesPublisher: MDPI AGVol: 27Issue #: 2Start Page: 507End Page: 507Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules27020507Best OA location URL: https://www.mdpi.com/1420-3049/27/2/507/pdf?version=1642149952Citation Count: 10
- Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care Concepts2022OPENTitle: Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care ConceptsJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 6Start Page: 921End Page: 921Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12060921Best OA location URL: https://www.mdpi.com/2075-4426/12/6/921/pdf?version=1654088438Citation Count: 3
- More than Just a Brain Disorder: A Five-Point Manifesto for Psychological Care for People with Huntington’s Disease2022OPENTitle: More than Just a Brain Disorder: A Five-Point Manifesto for Psychological Care for People with Huntington’s DiseaseJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 1Start Page: 64End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12010064Best OA location URL: https://www.mdpi.com/2075-4426/12/1/64/pdf?version=1641544992Citation Count: 22
- Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion2022OPENTitle: Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal ConversionJournal Name: Cellular ReprogrammingPublisher: Mary Ann Liebert IncVol: 24Issue #: 5Start Page: 304End Page: 313Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1089/cell.2021.0200Best OA location URL: https://doi.org/10.1089/cell.2021.0200Citation Count: 3
- A Sensor-Based Perspective in Early-Stage Parkinson’s Disease: Current State and the Need for Machine Learning Processes2022OPENTitle: A Sensor-Based Perspective in Early-Stage Parkinson’s Disease: Current State and the Need for Machine Learning ProcessesJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 2Start Page: 409End Page: 409Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22020409Best OA location URL: https://www.mdpi.com/1424-8220/22/2/409/pdf?version=1641453558Citation Count: 17
-
OPENTitle: One-Carbon Metabolism in Alzheimer’s Disease and Parkinson’s Disease Brain TissueJournal Name: NutrientsPublisher: MDPI AGVol: 14Issue #: 3Start Page: 599End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu14030599Best OA location URL: https://www.mdpi.com/2072-6643/14/3/599/pdf?version=1643524082Citation Count: 23
- Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease2022OPENTitle: Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s DiseaseJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 6Start Page: 2136End Page: 2136Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22062136Best OA location URL: https://www.mdpi.com/1424-8220/22/6/2136/pdf?version=1646901060Citation Count: 20
-
OPENTitle: Subcellular Fractionation for the Isolation of Synaptic Components from the Murine BrainJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 187Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/64574Best OA location URL: https://www.jove.com/pdf/64574/subcellular-fractionation-for-isolation-synaptic-components-fromCitation Count: 3
- Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein2022OPENTitle: Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-SynucleinJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 185Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/63313Best OA location URL: https://www.jove.com/pdf/63313/analyzing-parkinson-s-disease-mouse-model-induced-adeno-associatedCitation Count: 0
- Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease2022OPENTitle: Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201201Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01617%22Citation Count: 14
-
OPENTitle: Editorial introductionsJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 35Issue #: 1Start Page: viiEnd Page: ixPublication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000001027Citation Count: 0
- Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia2022OPENTitle: Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal DementiaJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200582Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9421596Citation Count: 2
-
OPENTitle: Lifestyle Interventions for the Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 42End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200787Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/42.full.pdfCitation Count: 32
-
OPENTitle: Quality of Life for Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741Best OA location URL: https://n.neurology.org/content/neurology/98/22/e2293.full.pdfCitation Count: 3
-
OPENTitle: Evaluation of Compensation Strategies for Gait Impairment in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1212/wnl.0000000000201159Best OA location URL: https://n.neurology.org/content/neurology/99/20/e2253.full.pdfCitation Count: 14
- Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease2022OPENTitle: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013218Best OA location URL: https://n.neurology.org/content/neurology/98/8/e859.full.pdfCitation Count: 68
- Association of Structural Measurements of Brain Reserve With Motor Progression in Patients With Parkinson Disease2022OPENTitle: Association of Structural Measurements of Brain Reserve With Motor Progression in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200814Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7613818Citation Count: 14
-
OPENTitle: Disease-Modifying Antirheumatic Drugs and Risk of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000013303Best OA location URL: https://n.neurology.org/content/neurology/98/12/e1273.full.pdfCitation Count: 20
- Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease2022OPENTitle: Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200113Best OA location URL: https://escholarship.org/content/qt7x25c6rb/qt7x25c6rb.pdfCitation Count: 42
-
OPENTitle: Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid AngiopathyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200136Best OA location URL: https://n.neurology.org/content/neurology/98/17/e1716.full.pdfCitation Count: 29
-
OPENTitle: Planning for Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200789Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdfCitation Count: 22
-
OPENTitle: Use of Whole-Genome Sequencing for Mitochondrial Disease DiagnosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200745Best OA location URL: https://n.neurology.org/content/neurology/99/7/e730.full.pdfCitation Count: 52
- Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)2022OPENTitle: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdfCitation Count: 3
- An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies2022OPENTitle: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 TherapiesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdfCitation Count: 1
-
OPENTitle: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200786Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdfCitation Count: 17
- Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls2022OPENTitle: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy ControlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdfCitation Count: 0
- The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis2022OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 2
-
OPENTitle: Interfacility Transfers for Seizure-Related Emergencies in the United StatesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9757868Citation Count: 5
- Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant2022OPENTitle: Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S VariantJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200737Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9484727Citation Count: 8
- Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 Sequences2022OPENTitle: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 SequencesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S17.1.full.pdfCitation Count: 1
-
OPENTitle: A Severe Case of Lupus CerebritisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S9.full.pdfCitation Count: 1
-
OPENTitle: A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/nxg.0000000000200008Best OA location URL: https://escholarship.org/content/qt15w1h7j8/qt15w1h7j8.pdfCitation Count: 7
-
OPENTitle: Genome Sequencing in the Parkinson Disease ClinicJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/nxg.0000000000200002Best OA location URL: https://ng.neurology.org/content/nng/8/4/e200002.full.pdfCitation Count: 15
-
OPENTitle: Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging StudyJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9647803Citation Count: 0
-
OPENTitle: “Stretched Slinky” SignJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200075Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9647796Citation Count: 3
- Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?2021OPENTitle: Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?Journal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 51Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1093/ageing/afab242Best OA location URL: https://academic.oup.com/ageing/article-pdf/51/1/afab242/42261496/afab242.pdfCitation Count: 10
-
OPENTitle: Neurofilament light levels predict clinical progression and death in multiple system atrophyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 12Start Page: 4398End Page: 4408Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awac253Best OA location URL: https://ibn.idsi.md/vizualizare_articol/218222Citation Count: 42
-
OPENTitle: Proposed research criteria for prodromal behavioural variant frontotemporal dementiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1079End Page: 1097Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab365Best OA location URL: https://escholarship.org/content/qt4238f45w/qt4238f45w.pdfCitation Count: 77
- Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord2022OPENTitle: Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cordJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 9Start Page: 3108End Page: 3130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac165Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/febe7b1e-5f00-453d-aba7-3c0912f53219Citation Count: 54
-
OPENTitle: ATXN2 intermediate expansions in amyotrophic lateral sclerosisJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2671End Page: 2676Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac167Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2671/49017873/awac167.pdfCitation Count: 33
-
OPENTitle: Mitochondrial haplogroups and cognitive progression in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 1Start Page: 42End Page: 49Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac327Best OA location URL: https://academic.oup.com/brain/article-pdf/146/1/42/50417168/awac327.pdfCitation Count: 19
-
OPENTitle: Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 7Start Page: 2541End Page: 2554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac177Best OA location URL: https://academic.oup.com/brain/article-pdf/145/7/2541/45191149/awac177.pdfCitation Count: 65
-
OPENTitle: Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 2Start Page: 507End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac294Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10169283Citation Count: 15
-
OPENTitle: Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 6Start Page: 2077End Page: 2091Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab456Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9423714Citation Count: 54
-
OPENTitle: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2629End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac281Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2629/45599741/awac281.pdfCitation Count: 1
- Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression2022OPENTitle: Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expressionJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 9Start Page: 3162End Page: 3178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac187Best OA location URL: https://academic.oup.com/brain/article-pdf/145/9/3162/45824139/awac187.pdfCitation Count: 38
-
OPENTitle: Adult-onset KMT2B-related dystoniaJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac276Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac276/47057049/fcac276.pdfCitation Count: 9
-
OPENTitle: Integrating multi-omics summary data using a Mendelian randomization frameworkJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bib/bbac376Best OA location URL: https://doi.org/10.1093/bib/bbac376Citation Count: 14
-
OPENTitle: Analysis of Y chromosome haplogroups in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1093/braincomms/fcac277Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac277/47057066/fcac277.pdfCitation Count: 8